Evidence map›Paper›PMID 40292890›Full record

ArticleSensors (Basel, Switzerland)2025

A Novel Explainable Attention-Based Meta-Learning Framework for Imbalanced Brain Stroke Prediction.

Inam Abousaber

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Inam AbousaberDepartment of Information Technology, Faculty of Computers and Information Technology, University of Tabuk, Tabuk 47912, Saudi Arabia.ORCID 0000-0003-0001-1300

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The accurate prediction of brain stroke is critical for effective diagnosis and management, yet the imbalanced nature of medical datasets often hampers the performance of conventional machine learning models. To address this challenge, we propose a novel meta-learning framework that integrates advanced hybrid resampling techniques, ensemble-based classifiers, and explainable artificial intelligence (XAI) to enhance predictive performance and interpretability. The framework employs SMOTE and SMOTEENN for handling class imbalance, dynamic feature selection to reduce noise, and a meta-learning approach combining predictions from Random Forest and LightGBM, and further refined by a deep learning-based meta-classifier. The model uses SHAP (Shapley Additive Explanations) to provide transparent insights into feature contributions, increasing trust in its predictions. Evaluated on three datasets, DF-1, DF-2, and DF-3, the proposed framework consistently outperformed state-of-the-art methods, achieving accuracy and F1-Score of 0.992189 and 0.992579 on DF-1, 0.980297 and 0.981916 on DF-2, and 0.981901 and 0.983365 on DF-3. These results validate the robustness and effectiveness of the approach, significantly improving the detection of minority-class instances while maintaining overall performance. This work establishes a reliable solution for stroke prediction and provides a foundation for applying meta-learning and explainable AI to other imbalanced medical prediction tasks.

Indexed as

AttentionBrainMachine LearningStrokeAlgorithmsArtificial IntelligenceDeep LearningHumansensemble learning modelsexplainable artificial intelligencefeature interaction analysisimbalanced dataset handlingmedical data analysismeta-learning frameworkprecision medicineSHAP explainabilitySMOTE and SMOTEENNstroke prediction

Identifiers

PMID40292890
PMCPMC11945820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.